What causes a brain aneurysm?
Brain aneurysms can happen to anyone at any age, but are most common in adults between the ages of 30 and 60, as well as women, and in those with certain inherited disorders. According to the Brain Aneurysm Foundation Brain aneurysms are also not rare one in every 50 people, or about 6.5 million people in the US have an unruptured brain aneurysm. How is a brain aneurysm treated?
Treatment for a brain aneurysm depends on the type, size, and location of the aneurysm, risk of rupture, the person s age and health, personal and family medical history, and risk of treatment.
Virus can damage brain without infecting it; hair loss on rise among minorities during pandemic
FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS. reuters tickers
This content was published on January 6, 2021 - 22:12
January 6, 2021 - 22:12
By Nancy Lapid
(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Blood vessel damage, inflammation in COVID-19 patients tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Blood vessel damage, inflammation in COVID-19 patients brains: Study ANI | Updated: Jan 03, 2021 13:50 IST
Washington [US], January 3 (ANI): A team of researchers from National Institutes of Health, in an in-depth study of how COVID-19 affects a patient s brain, have consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples. These damage hallmarks were spotted in patients who died shortly after contracting the disease.
In addition, they saw no signs of SARS-CoV-2 in the tissue samples, suggesting the damage was not caused by a direct viral attack on the brain. The results were published as correspondence in the New England Journal of Medicine.